Synthesis and biological evaluation of bis[3-(3-alkoxy-1,2,5-thiadiazole-4-yl)-1,2,5,6-tetrahydro-pyrid-1-yl] alkane dihydrochlorides as muscarinic agonists

被引:0
|
作者
Cao, Y [1 ]
Wroblewski, ME [1 ]
Nagy, PI [1 ]
Messer, WS [1 ]
机构
[1] Univ Toledo, Coll Pharm, Dept Med & Biol Chem, Toledo, OH 43606 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
22
引用
收藏
页码:2625 / 2625
页数:1
相关论文
共 50 条
  • [1] MUSCARINIC ANTAGONIST ACTIVITY OF 3-(5-ALKOXY-OXAZOL-2-YL)-1,2,5,6-TETRAHYDROPYRIDINES
    MITCH, CH
    BYMASTER, FP
    CALLIGARO, DO
    QUIMBY, SJ
    SCHOEPP, DD
    WONG, DT
    SHANNON, HE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (14) : 1721 - 1724
  • [2] Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine. Synthesis, receptor affinity, and antinociceptive activity
    Sauerberg, P
    Olesen, PH
    Sheardown, MJ
    Rimvall, K
    Thogersen, H
    Shannon, HE
    Sawyer, BD
    Ward, JS
    Bymaster, FP
    DeLapp, NW
    Calligaro, DO
    Swedberg, MDB
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (01) : 109 - 116
  • [3] Synthesis of 5-(4-alkoxy-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydropyrimidine oxalate salts and their evaluation as muscarinic receptor agonists
    Park, JG
    Lee, MJ
    Kong, JY
    Jung, MH
    [J]. ARCHIV DER PHARMAZIE, 2000, 333 (05) : 113 - 117
  • [4] NOVEL FUNCTIONAL-M1 SELECTIVE MUSCARINIC AGONISTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 3-(1,2,5-THIADIAZOLYL)-1,2,5,6-TETRAHYDRO-1-METHYLPYRIDINES
    SAUERBERG, P
    OLESEN, PH
    NIELSEN, S
    TREPPENDAHL, S
    SHEARDOWN, MJ
    HONORE, T
    MITCH, CH
    WARD, JS
    PIKE, AJ
    BYMASTER, FP
    SAWYER, BD
    SHANNON, HE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (12) : 2274 - 2283
  • [5] Identification of metabolites of fluorine-18-labeled M2 muscarinic receptor agonist, 3-(3-[(3-fluoropropyl)thio]-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine, produced by human and rat hepatocytes
    Ma, Y
    Kiesewetter, DO
    Jagoda, EM
    Huang, BX
    Eckelman, WC
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 766 (02): : 319 - 329
  • [6] Design, synthesis, and biological characterization of bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as selective muscarinic agonists
    Rajeswaran, WG
    Cao, Y
    Huang, XP
    Wroblewski, ME
    Colclough, T
    Lee, S
    Liu, FH
    Nagy, PI
    Ellis, J
    Levine, BA
    Nocka, KH
    Messer, WS
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (26) : 4563 - 4576
  • [7] Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders
    Cao, Y
    Zhang, MJ
    Wu, C
    Lee, S
    Wroblewski, ME
    Whipple, T
    Nagy, PI
    Takács-Novák, K
    Balázs, A
    Törös, S
    Messer, WS
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (20) : 4273 - 4286
  • [8] Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): Effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras
    Tejada, Frederick R.
    Nagy, Peter I.
    Xu, Min
    Wu, Cindy
    Katz, Tricia
    Dorsey, Jason
    Rieman, Melissa
    Lawlor, Elizabeth
    Warrier, Manya
    Messer, William S., Jr.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (25) : 7518 - 7531
  • [9] 3-(4-Amino-1,2,5-oxadiazol-3-yl)-4-(4-nitro-1,2,5-oxadiazol-3yl)-1,2,5-oxadiazole
    Pagoria, Philip
    Zhang, Maoxi
    Racoveanu, Ana
    DeHope, Alan
    Tsyshevsky, Roman
    Kuklja, Maija M.
    [J]. MOLBANK, 2014, (02)
  • [10] Synthesis, Crystal Structure and Bioactivities of 1-(4-Chlorophenyl)-3-[5-(pyrid-4-yl)-1,3,4-thiadiazol-2-yl]urea
    宋新建
    刘信平
    谭小红
    汪焱钢
    [J]. 结构化学, 2007, (04) : 467 - 471